Skip to main content

Peroxisome Proliferator-Activated Receptor (PPAR)

  • Reference work entry
  • First Online:
  • 289 Accesses

Synonyms

NR1C1; NR1C2; NR1C3; PPARα; PPARβ/δ; PPARγ

Historical Background

PPARs were initially discovered while delineating mechanisms that induce peroxisome proliferation in rodents, hence the name of peroxisome proliferator-activated receptor. PPARα was the first identified isoform cloned from a mouse liver complementary DNA library in 1990 from researchers working on the mechanisms implicated in the promoting action of a variety of chemicals on peroxisomal proliferation in the rodent liver (Issemann and Green 1990). The identified protein presented a high degree of similarity with several members of the nuclear hormone receptor superfamily and was highly expressed in liver, kidney, heart, and brown adipose tissue. Τhe other two PPAR isoforms called PPARβ/δ and PPARγ were later identified in Xenopus laevis (Dreyer et al. 1992), human (Greene et al. 1995), and mouse (Chen et al. 1993).

PPAR Structure

PPARs’ basic structure includes several domains which interact with each other for...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Barlaka E, Galatou E, Mellidis K, Ravingerova T, Lazou A. Role of pleiotropic properties of peroxisome proliferator-activated receptors in the heart: focus on the nonmetabolic effects in cardiac protection. Cardiovasc Ther. 2016;34(1):37–48.

    Article  CAS  PubMed  Google Scholar 

  • Braissant O, Foufelle F, Scotto C, Dauça M, Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, −β, and -γ in the adult rat. Endocrinology. 1996;137(1):354–66.

    Article  CAS  PubMed  Google Scholar 

  • Bugge A, Mandrup S. Molecular mechanisms and genome-wide aspects of PPAR subtype specific transactivation. PPAR Res. 2010; 169506: 1–12.

    Article  CAS  Google Scholar 

  • Cantini G, Lombardi A, Borgogni E, et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism. Eur J Cell Biol. 2010;89:645–53.

    Article  CAS  PubMed  Google Scholar 

  • Chen F, Law SW, O’Malley BW. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochem Biophys Res Commun. 1993;196:671–7.

    Article  CAS  PubMed  Google Scholar 

  • Coleman JD, Prabhu KS, Thompson JT, Reddy PS, Peters JM, Peterson BR, Reddy CC, Vanden Heuvel JP. The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator activated receptor-beta/delta (PPARbeta/delta). Free Radic Biol Med. 2007;42:1155–64.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Couffinhal T, Dufourcq P, Barandon L, Leroux L, Duplaa C. Mouse models to study angiogenesis in the context of cardiovascular diseases. Front Biosci. 2009;14:3310–25.

    Article  CAS  Google Scholar 

  • Daynes RA, Jones DC. Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol. 2002;2:748–59.

    Article  CAS  PubMed  Google Scholar 

  • Desvergne B, Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev. 1999;20:649–88.

    PubMed  CAS  Google Scholar 

  • Dreyer C, Krey G, Keller H, Givel F, Helftenbein G, Wahli W. Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors. Cell. 1992;68:879–87.

    Article  CAS  PubMed  Google Scholar 

  • Feige JN, Gelman L, Tudor C, Engelborghs Y, Wahli W, Desvergne B. Fluorescence imaging reveals the nuclear behavior of peroxisome proliferator-activated receptor/retinoid X receptor heterodimers in the absence and presence of ligand. J Biol Chem. 2005;280:17880–90.

    Article  CAS  PubMed  Google Scholar 

  • Feige JN, Gelman L, Michalik L, Desvergne B, Wahli W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res. 2006;45:120–59.

    Article  CAS  PubMed  Google Scholar 

  • Finck BN. The PPAR regulatory system in cardiac physiology and disease. Cardiovasc Res. 2007;73(2):269–77.

    Article  CAS  PubMed  Google Scholar 

  • Fuentes L, Roszer T, Ricote M. Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages. Mediators Inflamm. 2010;2010:219583.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, Hsieh L, Greene G, Nimer SD. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr. 1995;4:281–99.

    PubMed  CAS  Google Scholar 

  • Grimaldi PA. Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives. Cell Mol Life Sci. 2007;64:2459–64.

    Article  CAS  PubMed  Google Scholar 

  • Gupta RA, Tan J, Krause WF, et al. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer. Proc Natl Acad Sci USA. 2000;97:13275–80.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hummasti S, Tontonoz P. The peroxisome proliferator activated receptor N-terminal domain controls isotype selective gene expression and adipogenesis. Mol Endocrinol. 2006;20:1261–75.

    Article  CAS  PubMed  Google Scholar 

  • Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645–50.

    Article  CAS  PubMed  Google Scholar 

  • Karin M. Inflammation and cancer: the long reach of Ras. Nat Med. 2005;11(1):20–1.

    Article  CAS  PubMed  Google Scholar 

  • Lalloyer F, Staels B. Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol. 2010;30:894–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Luconi M, Cantini G, Serio M. Peroxisome proliferator activated receptor gamma (PPARgamma): is the genomic activity the only answer? Steroids. 2010;75:585–94.

    Article  CAS  PubMed  Google Scholar 

  • Menéndez-Gutiérrez MP, Roszer M, Ricote M. Biology and therapeutic applications of peroxisome proliferator-activated receptors. Curr Topics Med Chem. 2012;12:548–84.

    Article  Google Scholar 

  • Michalik L, Desvergne B, Wahli W. Peroxisome-proliferator activated receptors and cancers: complex stories. Nat Rev Cancer. 2004;4(1):61–70.

    Article  CAS  PubMed  Google Scholar 

  • Mitro N, Godio C, Crestani M. Fluorescence resonance energy transfer techniques to study ligand-mediated interactions of PPARs with coregulators. Methods Mol Biol. 2013;952:219–27.

    Article  CAS  PubMed  Google Scholar 

  • Neels JG, Grimaldi PA. Physiological functions of peroxisome proliferator-activated receptor β. Physiol Rev. 2014;94:795–858.

    Article  CAS  PubMed  Google Scholar 

  • Ravingerova T, Adameova A, Carnicka S, Nemcekova M, Kelly T, Matejikova J, Galatou E, Barlaka E, Lazou A. The role of PPAR in myocardial response to ischemia in normal and diseased heart. Gen Physiol Biophys. 2011;30:329–41.

    Article  CAS  PubMed  Google Scholar 

  • Salam NK, Huang TH, Kota BP, Kim MS, Li Y, Hibbs DE. Novel PPAR-gamma agonists identified from a natural product library: a virtual screening, induced-fit docking and biological assay study. Chem Biol Drug Des. 2008;71:57–70.

    Article  CAS  PubMed  Google Scholar 

  • Theocharis S, Margeli A, Vielh P, Kouraklis G. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators. Cancer Treat Rev. 2004;30:545–54.

    Article  CAS  PubMed  Google Scholar 

  • van Bilsen M, van Nieuwenhoven FA. PPARs as therapeutic targets in cardiovascular disease. Exp Opin Ther Targets. 2010;14(10):1029–45.

    Article  CAS  Google Scholar 

  • Xu HE, Lambert MH, Montana VG, et al. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA. 2001;98:13919–24.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Zoete V, Grosdidier A, Michielin O. Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators. Biochim Biophys Acta. 2007;1771:915–25.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antigone Lazou .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Lazou, A., Barlaka, E. (2018). Peroxisome Proliferator-Activated Receptor (PPAR). In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101829

Download citation

Publish with us

Policies and ethics